Stephen J.LurieMD, PhD, Senior EditorIndividualAuthorJody W.ZylkeMD, Contributing EditorIndividualAuthor
To the Editor: Dr Lipton and colleagues1 failed to discuss several important issues associated with migraine therapy. The patients were stratified using MIDAS scores, which are influenced largely by the frequency of disabling headaches. The authors dismissed patients with grade I disability by simply asserting that their attacks "do not warrant treatment with a triptan." However, a person with infrequent severe disabling migraines with resulting work absenteeism could score grade I on the MIDAS. Such attacks would certainly warrant triptan therapy.
Cady RK. Treatment Strategies for Migraine Headache. JAMA. 2001;285(8):1014-1015. doi:10.1001/jama.285.8.1013